[Skin necrosis induced by heparin: apropos of 2 cases].
Andolfatto
S
S
Service d'hématologie biologique, CHU Nancy Brabois, avenue du Morvan, 54511 VandOEuvre-lès-Nancy cedex.
Latger-Cannard
V
V
Maistre
E D
ED
Briquel
M E
ME
André
E
E
Montange
F
F
Reichert
S
S
Lecompte
T
T
D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000990:Antithrombin III / Q000008:administration & dosage / Q000627:therapeutic use; D002809:Chondroitin Sulfates / Q000008:administration & dosage / Q000627:therapeutic use; D003871:Dermatan Sulfate / Q000008:administration & dosage / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006493:Heparin / Q000009:adverse effects*; D006497:Heparan Sulfate / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D017762:Nadroparin / Q000009:adverse effects*; D009336:Necrosis; D010976:Platelet Count; D012867:Skin / Q000473:pathology; D012871:Skin Diseases / Q000139:chemically induced*
D000925:Anticoagulants; D000990:Antithrombin III; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D005343:Fibrinolytic Agents; D006493:Heparin; D006497:Heparan Sulfate; D017762:Nadroparin; C035838:danaparoid
Nécroses cutanées induites par l'héparine: à propos de deux cas.